Physician profile
John P Bartlett
NPI 1821090994
$1,895.91
in general payments reported to CMS, 2019-2025
22 companies · $85.67 in 2025
The $85.67 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.34 · 2020: $262 · 2021: $464 · 2022: $700 · 2023: $267 · 2024: $77.82 · 2025: $85.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $430.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $430.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $464.00 | 2021-2023 | Qulipta, Vraylar |
| Bayer Healthcare Pharmaceuticals INC. | $214.47 | 2021-2022 | |
| Pfizer INC. | $151.47 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $151.17 | 2021-2024 | Vaxelis, Gardasil 9, Vaxneuvance |
| Amgen INC. | $130.33 | 2022-2025 | Repatha, Otezla, Otezla |
| Novartis Pharmaceuticals Corporation | $124.39 | 2020-2023 | |
| Lilly USA, LLC | $82.04 | 2022-2023 | Mounjaro |
| Astrazeneca Pharmaceuticals LP | $71.66 | 2023 | Evusheld |
| Boehringer Ingelheim Pharmaceuticals, INC. | $69.44 | 2019-2022 | |
| Glaxosmithkline, LLC. | $67.84 | 2019-2025 | Shingrix |
| Horizon Therapeutics Plc | $67.48 | 2021-2023 | Krystexxa |
| Amarin Pharma, INC. | $48.38 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $46.46 | 2020-2021 | |
| Allergan, INC. | $38.62 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $31.00 | 2020-2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $28.73 | 2021-2022 | |
| Novo Nordisk INC | $27.39 | 2020-2022 | |
| Biohaven Pharmaceuticals, INC. | $22.54 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $16.17 | 2022 | |
| Baxter Healthcare | $15.91 | 2022 | |
| Philips North America LLC | $13.70 | 2023 | |
| Organon LLC | $12.72 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Bartlett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.